COMPANY PROFILE / #1315
Basecamp Research
London, United KingdomVenture Capital-Backed
OVERVIEW
Developer of a biological-design platform designed to explore and recreate the full complexity of natural biodiversity. The company's platform uses a massive, ethically-sourced biological knowledge graph and AI-driven tools to map biodiversity at scale, reconstruct multiple novel protein sequences, model full biological context, and design new proteins and genomes, enabling research and biotech organizations to develop novel therapeutics, food, agriculture, and other biologically-derived products with innovation and potential beyond traditional methods.
已融资83.54
最新估值177.04
员工数48
成立年份2019
公司概况
- Companies
- Basecamp Research
- Description
- Developer of a biological-design platform designed to explore and recreate the full complexity of natural biodiversity. The company's platform uses a massive, ethically-sourced biological knowledge graph and AI-driven tools to map biodiversity at scale, reconstruct multiple novel protein sequences, model full biological context, and design new proteins and genomes, enabling research and biotech organizations to develop novel therapeutics, food, agriculture, and other biologically-derived products with innovation and potential beyond traditional methods.
- Website
- www.basecamp-research.com
- HQ Location
- London, United Kingdom
- Year Founded
- 2019
- Keywords
- artificial intelligence engine, artificial intelligence process, biodiversity assessment, biodiversity data, biodiversity research, biological data management, proteins development
- Competitors
- Deep Genomics, Protai Bio, Arbor Biotechnologies, Numerate, Caris Life Sciences, ATUM (Biotechnology), Genesis Molecular AI, AI Proteins, Ansa Biotechnologies, Editas Medicine, Verge Analytics, BPS Bioscience, Sygnature Discovery, X-37, Homology Medicines, Exscientia, Molecular Assemblies, LaserGen, Integrated DNA Technologies, NuMedii, Personal Genome Diagnostics, Twist Bioscience, CRISPR Therapeutics, Origene, Vizgen, DNA Script, GnuBIO, Scipher Medicine, Phase Genomics, Ordaos, Knome (US), Eurofins Genomics Europe Shared Services, Standard BioTools, Intellia Therapeutics, RainDance Technologies, Evonetix, Nuclera, Genomic Vision, New England Biolabs, Numerion Labs, Verve Therapeutics, ERS Genomics, CD Genomics, NanoString Technologies, Mammoth Biosciences, Active Motif, EpiGentek Group, Quantapore, Eurofins Genomics Blue Heron, ArcherDX, Personalis, Genomic Expression, Oxford Nanopore Technologies, Berg, Owkin, Cyclica, Cradle (Healthcare Technology Systems)
- Ownership Status
- Privately Held (backing)
- Company Financing Status
- Venture Capital-Backed
融资与估值
- Total Raised
- 83.54
- First Financing Date
- 01-Jan-2020
- First Financing Size
- 1.31
- First Financing Valuation
- 4.72
- Last Financing Date
- 12-Jan-2026
- Last Financing Deal Type
- Later Stage VC
- Last Financing Size
- —
- Last Financing Valuation
- —
- Last Financing Status
- Completed
- Last Known Valuation
- 177.04
- Last Known Valuation Date
- 08-Oct-2024
- Last Known Valuation Deal Type
- Later Stage VC
- Valuation Estimate
- 275.18
- Valuation Estimate Growth Rate
- 55.44%
- Active Investors
- Andre Hoffmann, Andy Conrad, Blue Horizon Corporation, Feike Sijbesma, Hummingbird Ventures, King Philanthropies, Manatu, Microsoft for Startups, nVentures, NVentures (Santa Clara), Paul Polman, Redalpine, S32, Singular., Systemiq Capital, True Ventures, Valo, Valo Ventures
- # Active Investors
- 18
- Acquirers
- —
团队与联系人
- Employees
- 48
- Employee Growth %
- 45.45%
- Employee History
- 2025: 48, 2024: 33, 2023: 30, 2022: 22, 2021: 10, 2020: 4
- Primary Contact
- Glen Gowers
- Primary Contact Title
- Co-Founder & Chief Executive Officer
- Primary Contact Email
- glen@basecamp-research.com
- Primary Contact Phone
- —
增长与经营
- Revenue
- —
- Revenue Growth %
- —
- Growth Rate
- —
- Growth Rate % Change
- —
- Growth Rate Percentile
- —
- Size Multiple
- —
- Size Multiple % Change
- —
- Size Multiple Change
- —
- Size Multiple Percentile
- —
- Majestic Referring Domains
- —
- SimilarWeb Unique Visitors
- —
- SimilarWeb Unique Visitors Change
- —
- SimilarWeb Growth Rate
- —
- SimilarWeb Growth Rate Percentile
- —
- Success Probability Over Time – 1 Year
- 18%
- Success Probability Over Time – 3 Year
- 36%
- Success Probability Over Time – 5 Year
- 47%
记录来源：public.companies · 原始序号 #1315 · 所有字段均按数据库原值展示。